I think gene therapy and nanotechnology go hand in hand.

Hundreds of people are undergoing gene therapy today. There are no known neurological issues.

Currently, we are working to deliver our anti-aging gene therapies to terminally ill people for compassionate care. Although, in the future we think that preventative medicine against aging would begin at a much younger age.

I think dry nanotechnology is probably a dead-end.

I think chemistry and great acting go hand-in-hand.

We have a battery of tests planned at regular intervals including DNA methylation analysis, gene expression profile changes, telomere length (both TAT and QTRAP measured) and various other metrics that will highlight positive changes to aging biomarkers.